Sickle cell disease is a set of illnesses characterized by the misshaping and breakdown of red blood cells. Red blood cells twist into a sickle shape in sickle cell disease, an inherited set of illnesses. The cells die early, resulting in a lack of healthy red blood cells (sickle cell anemia), and they might impede blood flow, causing pain (sickle cell crisis). Vernon Mason coined the term "sickle cell anemia" in 1922. SCD is thought to have killed approximately 114,800 individuals worldwide, and it is more common among people whose ancestors lived in tropical and subtropical sub-Saharan Africa, where malaria is or was prevalent. There are several types of SCD, including homozygous HbS and HbS/HbC co-inheritance (usually called HbSC). A genetic mutation causes the condition, which disrupts the iron-rich molecule essential for making blood red and transporting oxygen. SCD has been treated using a variety of approaches. The use of hydroxycarbamide and L-glutamine, blood transfusions, bone marrow transplants, gene therapy, and nutritional supplementation are just a few of them. Gene therapy is the most effective treatment option on the list. The method relies on modifying and reprogramming cells from the patient's own blood cells, as well as genetic engineering, to fix the inborn genetic defect. hydroxyurea, on the other hand, has been shown to change the course of the disease. Finally, if utilized correctly, a combination of available therapeutic medications could greatly improve the disease.
Adio et al. (Tue,) studied this question.